Local recurrence in extremity soft tissue sarcoma is strongly associated with subsequent metastasis, which was predicted by initial high-grade (risk 3.5; P=0.005) or deep (risk 2.9; P=0.02) tumors.
Cohort (n=911)
No
Does local recurrence predict subsequent metastasis and disease-specific survival in patients with primary extremity soft tissue sarcoma?
Local recurrence in extremity soft tissue sarcoma is strongly associated with subsequent metastasis and tumor mortality, particularly in patients with high-grade, deep, or large primary tumors.
PURPOSE The aim of this study was to analyze local recurrence in a large cohort of prospectively followed patients with primary extremity soft tissue sarcoma. In particular, we analyzed the correlation of local recurrence with subsequent metastasis and disease-specific survival. PATIENTS AND METHODS Patients who underwent treatment for primary extremity soft tissue sarcoma from July 1982 through July 1995 at Memorial Sloan-Kettering Cancer Center were the subject of this study. Local recurrence, distant metastasis, and disease-specific survival were used as end points of the study. The influence of local recurrence on subsequent distant metastasis and disease-specific survival were examined using the Cox proportional hazards model. RESULTS We treated 911 patients, of whom 297 (33%) developed recurrent disease. Local recurrence occurred in 116 patients (13%), metastasis in 167 (18%), and synchronous local recurrence and metastasis in 13 (2%). Of 116 patients who developed local recurrence, 38 subsequently developed metastasis and 34 died of disease. Metastasis after local recurrence was predicted in patients with initial high-grade (P = .005; risk = 3.5) or deep (P = .02; risk = 2.9) tumors. Tumor mortality after local recurrence was predicted in patients with initial high-grade (P = .007; risk = 3.7) or large (> 5 cm; P = .01; risk = 3.2) primary tumors. DISCUSSION These findings suggest that there is a strong association of local recurrence with the development of subsequent metastasis and tumor mortality, and that local recurrence is a poor prognostic factor. It would seem prudent to consider patients who develop local recurrence and have high-grade tumors as being at high risk for systemic disease and therefore eligible for investigational adjuvant systemic therapy.
Lewis et al. (Sat,) conducted a cohort in Primary extremity soft tissue sarcoma (n=911). Local recurrence was evaluated on Local recurrence, distant metastasis, and disease-specific survival. Local recurrence in extremity soft tissue sarcoma is strongly associated with subsequent metastasis, which was predicted by initial high-grade (risk 3.5; P=0.005) or deep (risk 2.9; P=0.02) tumors.